Clinical Genetic Test
offered by
GTR Test Accession:
Help
GTR000552567.2
Last updated in GTR:
2024-10-31
View version history
GTR000552567.2,
last updated:
2024-10-31
GTR000552567.1,
registered in GTR:
2017-01-20
Last annual review date for the lab: 2024-10-31
LinkOut
At a Glance
Test purpose:
Help
Risk Assessment;
Screening
Conditions (327):
Help
FRAXE;
3-methylcrotonyl-CoA carboxylase 1 deficiency;
3-methylcrotonyl-CoA carboxylase 2 deficiency
more...
Genes (300):
Help
Methods (1):
Help
Molecular Genetics - Sequence analysis of the entire coding region: Next-Generation (NGS)/Massively parallel sequencing (MPS)
Target population: Help
Preconceptional context
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Specimen Source:
Help
- Isolated DNA
- Peripheral (whole) blood
- Saliva
Who can order: Help
- Genetic Counselor
- Health Care Provider
- Licensed Physician
- Physician Assistant
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
To order a test it must be filled in the service request form (in PDF format) that can be downloaded directly from the website and edited. Once completed, it shall be send along with the sample to analyze. We process DNA or another biological samples (pre and postnatal, see details …
Order URL
Test service:
Help
Confirmation of research findings
Comment: contact our team
Custom Sequence Analysis
OrderCode: qCarrier Plus
Genetic counseling
Comment: contact our team
Identity Testing
ECS
Carrier testing
OrderCode: qCarrier
Uniparental Disomy (UPD) Testing
Comment: contact our team
Comment: contact our team
Custom Sequence Analysis
OrderCode: qCarrier Plus
Genetic counseling
Comment: contact our team
Identity Testing
ECS
Carrier testing
OrderCode: qCarrier
Uniparental Disomy (UPD) Testing
Comment: contact our team
Test additional service:
Help
Custom Prenatal Testing
OrderCode: qChip Pre
Custom Prenatal Testing
OrderCode: qChip Post
OrderCode: qChip Pre
Custom Prenatal Testing
OrderCode: qChip Post
Informed consent required:
Help
Yes
Pre-test genetic counseling required:
Help
Yes
Post-test genetic counseling required:
Help
Yes
Recommended fields not provided:
Test Order Code,
Lab contact for this test,
Test strategy,
Test development
Conditions
Help
Total conditions: 327
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 300
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Risk Assessment;
Screening
Target population:
Help
Preconceptional context
View citations (1)
- Abulí A, Boada M, Rodríguez-Santiago B, Coroleu B, Veiga A, Armengol L, Barri PN, Pérez-Jurado LA, Estivill X. NGS-Based Assay for the Identification of Individuals Carrying Recessive Genetic Mutations in Reproductive Medicine. Hum Mutat. 2016;37(6):516-23. doi:10.1002/humu.22989. Epub 2016 Apr 15. PMID: 26990548.
Variant Interpretation:
What is the protocol for interpreting a variation as a VUS?
Help
We interpret and report the patogenic, benign and VUS variants according to the array guidelines and recommendations following the American Collegue of Medical Genetics.
We interpret and report the patogenic, benign and VUS variants according to the array guidelines and recommendations following the American Collegue of Medical Genetics.
Are family members with defined clinical status recruited to assess significance of VUS without charge?
Help
Decline to answer.
Decline to answer.
Will the lab re-contact the ordering physician if variant interpretation changes?
Help
Not provided. We re-evaluate prior interpretations while generating new reports. If a new syndrome or new genes have been described in the altered region of a previous report, we generate a new report and contact to the clinician.
Not provided. We re-evaluate prior interpretations while generating new reports. If a new syndrome or new genes have been described in the altered region of a previous report, we generate a new report and contact to the clinician.
Recommended fields not provided:
Clinical validity,
Clinical utility,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
sensitivity >96%
specificity >99%
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
No
No
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
PT Provider,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
Not Applicable
Additional Information
Reviews:
Clinical resources:
Molecular resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.